By Nick Malinowski ( July 14, 2010, 4:33 PM EDT) -- A divided U.S. Food and Drug Administration advisory committee voted Wednesday to keep GlaxoSmithKline PLC's troubled diabetes drug Avandia on the market, although nearly one-third of the panelists recommended that the pill be banned outright....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.